Alivus Life Sciences Limited (GLS)
Healthcare | Drug Manufacturers - Specialty & Generic
₹1086.0
0.15%
Margin Metrics
| Gross Margin | 53.3% |
| Operating Margin | 28.5% |
| Net Margin | 21.6% |
Return Metrics
| Return on Equity (ROE) | 0.0% |
| Return on Assets (ROA) | 16.5% |
| Return on Invested Capital (ROIC) | 2721.0% |
Profitability Analysis Score: 80/100
Profitability Score: 80/100
Key Performance Indicators:
- Excellent cost management with gross margin above 40%
- Superior operational efficiency with margin above 25%
- Excellent profitability with net margin above 20%
- Excellent capital efficiency with ROIC above 20%
Recommendation
Exceptional Profitability - Company demonstrates superior financial performance and efficiency
Detailed Analysis
Margin Analysis: Gross margin of 53.3% indicates exceptional cost management.
Operational Efficiency: Operating margin of 28.5% shows excellent operational control.
Bottom Line: Net margin of 21.6% demonstrates superior overall profitability.
Risk Assessment Guide
- Score 80-100: Superior profitability with strong competitive advantages
- Score 60-79: Healthy profitability with good market position
- Score 40-59: Average profitability with improvement opportunities
- Score Below 40: Weak profitability requiring strategic intervention
Key Metrics
- Return on Equity: 0.0%
- Return on Invested Capital: 2721.0%
- Return on Assets: 16.5%
Last Updated: 23-Jan-2025 06:48 AM